Literature DB >> 17012886

Preclinical and clinical safety studies on DNA vaccines.

Johanna A C Schalk1, Frits R Mooi, Guy A M Berbers, Leon A G J M van Aerts, Hans Ovelgönne, Tjeerd G Kimman.   

Abstract

DNA vaccines are based on the transfer of genetic material, encoding an antigen, to the cells of the vaccine recipient. Despite high expectations of DNA vaccines as a result of promising preclinical data their clinical utility remains unproven. However, much data is gathered in preclinical and clinical studies about the safety of DNA vaccines. Here we review current knowledge about the safety of DNA vaccines. Safety concerns of DNA vaccines relate to genetic, immunologic, toxic, and environmental effects. In this review we provide an overview of findings related to the safety of DNA vaccines, obtained so far. We conclude that the potential risks of DNA vaccines are minimal. However, their safety issues may differ case-by-case, and they should be treated accordingly.

Mesh:

Substances:

Year:  2006        PMID: 17012886     DOI: 10.4161/hv.2.2.2620

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  35 in total

Review 1.  Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA.

Authors:  Juergen Mairhofer; Reingard Grabherr
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

2.  Use of Staby(®) technology for development and production of DNA vaccines free of antibiotic resistance gene.

Authors:  Anca Reschner; Sophie Scohy; Gaëlle Vandermeulen; Marc Daukandt; Céline Jacques; Benjamin Michel; Hans Nauwynck; Florence Xhonneux; Véronique Préat; Alain Vanderplasschen; Cédric Szpirer
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

3.  Improved Specificity of Gene Electrotransfer to Skin Using pDNA Under the Control of Collagen Tissue-Specific Promoter.

Authors:  Spela Kos; Natasa Tesic; Urska Kamensek; Tanja Blagus; Maja Cemazar; Simona Kranjc; Jaka Lavrencak; Gregor Sersa
Journal:  J Membr Biol       Date:  2015-04-04       Impact factor: 1.843

Review 4.  Hypothesis driven development of new adjuvants: short peptides as immunomodulators.

Authors:  Jessica C Dong; Gary P Kobinger
Journal:  Hum Vaccin Immunother       Date:  2013-04-01       Impact factor: 3.452

5.  Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion.

Authors:  Willy M Bogers; Herman Oostermeijer; Petra Mooij; Gerrit Koopman; Ernst J Verschoor; David Davis; Jeffrey B Ulmer; Luis A Brito; Yen Cu; Kaustuv Banerjee; Gillis R Otten; Brian Burke; Antu Dey; Jonathan L Heeney; Xiaoying Shen; Georgia D Tomaras; Celia Labranche; David C Montefiori; Hua-Xin Liao; Barton Haynes; Andrew J Geall; Susan W Barnett
Journal:  J Infect Dis       Date:  2014-09-18       Impact factor: 5.226

6.  Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.

Authors:  Osmarie Martínez; Ariana Bravo Cruz; Saritza Santos; Maite Ramírez; Eric Miranda; Joanna Shisler; Miguel Otero
Journal:  Vaccine       Date:  2017-06-16       Impact factor: 3.641

Review 7.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

8.  A phase 1, randomized, controlled dose-escalation study of EP-1300 polyepitope DNA vaccine against Plasmodium falciparum malaria administered via electroporation.

Authors:  Paul Spearman; Mark Mulligan; Evan J Anderson; Andi L Shane; Kathy Stephens; Theda Gibson; Brooke Hartwell; Drew Hannaman; Nora L Watson; Karnail Singh
Journal:  Vaccine       Date:  2016-09-30       Impact factor: 3.641

9.  A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP.

Authors:  Sarah M McWhirter; Roman Barbalat; Kathryn M Monroe; Mary F Fontana; Mamoru Hyodo; Nathalie T Joncker; Ken J Ishii; Shizuo Akira; Marco Colonna; Zhijian J Chen; Katherine A Fitzgerald; Yoshihiro Hayakawa; Russell E Vance
Journal:  J Exp Med       Date:  2009-08-03       Impact factor: 14.307

10.  Prospects for control of emerging infectious diseases with plasmid DNA vaccines.

Authors:  Ronald B Moss
Journal:  J Immune Based Ther Vaccines       Date:  2009-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.